Commodore Capital as of Dec. 31, 2021
Portfolio Holdings for Commodore Capital
Commodore Capital holds 25 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iveric Bio | 12.5 | $54M | 3.2M | 16.72 | |
| Merus N V (MRUS) | 11.0 | $48M | 1.5M | 31.80 | |
| Aclaris Therapeutics (ACRS) | 9.0 | $39M | 2.7M | 14.54 | |
| Xenon Pharmaceuticals (XENE) | 7.9 | $34M | 1.1M | 31.24 | |
| Cytokinetics Com New (CYTK) | 7.4 | $32M | 705k | 45.58 | |
| Protagonist Therapeutics (PTGX) | 6.4 | $28M | 806k | 34.20 | |
| Bellus Health Com New | 5.8 | $25M | 3.1M | 8.05 | |
| Cogent Biosciences (COGT) | 4.5 | $20M | 2.3M | 8.58 | |
| Cymabay Therapeutics | 4.2 | $18M | 5.4M | 3.38 | |
| Miragen Therapeutics (VRDN) | 3.9 | $17M | 848k | 19.77 | |
| Satsuma Pharmaceuticals Ord | 3.9 | $17M | 3.7M | 4.50 | |
| Vistagen Therapeutics Com New | 3.8 | $17M | 8.5M | 1.95 | |
| C4 Therapeutics Com Stk (CCCC) | 3.6 | $16M | 481k | 32.20 | |
| Celcuity (CELC) | 2.8 | $12M | 921k | 13.19 | |
| Tricida | 2.8 | $12M | 1.2M | 9.56 | |
| Tenaya Therapeutics (TNYA) | 2.3 | $9.7M | 514k | 18.95 | |
| Allakos (ALLK) | 1.8 | $8.0M | 816k | 9.79 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $4.1M | 313k | 13.23 | |
| Kronos Bio (KRON) | 0.9 | $4.1M | 299k | 13.59 | |
| Dyne Therapeutics (DYN) | 0.8 | $3.6M | 305k | 11.89 | |
| Inventiva Sa Ads (IVA) | 0.8 | $3.6M | 263k | 13.66 | |
| Genocea Biosciences Com New (GNCAQ) | 0.8 | $3.6M | 3.1M | 1.16 | |
| Mereo Biopharma Group Ads (MREO) | 0.7 | $3.1M | 2.0M | 1.60 | |
| Pmv Pharmaceuticals (PMVP) | 0.7 | $2.9M | 125k | 23.10 | |
| Bcls Acquisition Corp Com Cl A | 0.6 | $2.5M | 250k | 9.80 |
